Drugs / Triptolide Wilfordii
Triptolide Wilfordii
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03403569 | Sep 2018 → Jun 2021 | HIV infectious disease | Peking Union Medical College Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Triptolide Wilfordii | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03403569 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Triptolide Wilfordii is a traditional Chinese herbal remedy” NCT03403569 ↗ |
| Route | Oral | “at a dosage of 20mg three times a day per os for 12 months.” NCT03403569 ↗ |